ALFA Finder
13:53 IST
BSE
Other Announcement
Medicamen Biotech Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Medicamen Biotech Ltd
- Share price
- ₹275.45
- Market cap
- ₹387.4 Cr
- Revenue (annual)
- ₹197.8 Cr
- Net profit (annual)
- ₹9.64 Cr
- P/E (TTM)
- 35.8×Sector 43.8×
- Promoter holding
- 42.57%+2.11% QoQ
- FII holding
- 4.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Other Announcement 3Board Meeting Date 3Annual General Meeting 3Preferential Issue 2Management Change 1Fund Raise 1Dividend 1Convertible Warrants 1Board Meeting Outcome 1
Time
3 announcements with these filters
17:00 IST
BSE
Other Announcement
Medicamen Biotech Other Announcement
Medicamen Biotech Limited's Director Sanjay Bansal sold 32,813 shares on the open market, as per a regulatory filing.
- Value
- ₹1.05 Cr
16:21 IST
BSE
Other Announcement
Medicamen Biotech Other Announcement
Medicamen Biotech Ltd clarified that an event reflected on the NSDL portal under its credentials was displayed inadvertently and incorrectly. The company confirmed no such event was authorized or initiated and is working with NSDL for rectification. There is no material information requiring disclosure at this time.